Financial calendar

2017 Full-Year Results: Wednesday, April 18, 2018

Shareholders’ General Meeting: Thursday, June 14, 2018

2018 Half-Year Results: Wednesday, September 19, 2018

Investors events

Scientific conferences

June 18 - 21, 2017: EAACI 2017, Helsinki

Poster: Efficacy of a 3-week subcutaneous immunotherapy course in patients with grass pollen-induced rhinoconjunctivitis: Results of a phase-3 study

Oral presentation : Short Course treatment of Subcutaneous Peptide Hydrolysate from Lolium Perenne - gp-ASIT+TM - suppresses Basophil Responses and induces IgG-associated Blocking Antibodies: A RDPCT